Latest News Feed

uBriGene Launches uVivo Lentiviral Vector Platform to Accelerate the Development of Next-Generation In Vivo CAR-T Therapies
Press Release Jul 16, 2026
uBriGene Launches uVivo Lentiviral Vector Platform to Accelerate the Development of Next-Generation In Vivo CAR-T Therapies

uBriGene unveils its patented uVivo™ Lentiviral Vector Platform, enabling targeted, scalable in vivo CAR-T therapies with efficient manufacturing.
uBriGene and Cellinfinity BIO Announce Strategic Partnership to Advance In Vivo CAR-T Therapies
Press Release Mar 30, 2026
uBriGene and Cellinfinity BIO Announce Strategic Partnership to Advance In Vivo CAR-T Therapies
uBriGene Congratulates Strategic Partner Grit Biotechnologies on FDA IND Clearance for Its Next-Generation GT307 TIL Therapy
Press Release Mar 16, 2026
uBriGene Congratulates Strategic Partner Grit Biotechnologies on FDA IND Clearance for Its Next-Generation GT307 TIL Therapy
uBriGene Launches LVV Turbo(TM) - Its Next-Generation GMP Lentiviral Vector Manufacturing Platform - and announces a Strategic Partnership with Syenex for integration of its UltraCell(TM) Technology
Press Release Dec 16, 2025
uBriGene Launches LVV Turbo(TM) - Its Next-Generation GMP Lentiviral Vector Manufacturing Platform - and announces a Strategic Partnership with Syenex for integration of its UltraCell(TM) Technology
Press Release Dec 9, 2025
uBriGene Biosciences and Circurna Announce Strategic Partnership to Accelerate Development and Manufacturing of Circular RNA/LNP Therapeutics
uBriGene Unveils V2.0 RNA-LNP iPSC Reprogramming Kit Optimized for PBMCs and Hard-to-Reprogram Cells
Press Release Sep 17, 2025
uBriGene Unveils V2.0 RNA-LNP iPSC Reprogramming Kit Optimized for PBMCs and Hard-to-Reprogram Cells
uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development
Press Release Jun 16, 2025
uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development
uBriGene Biosciences Submits Drug Master File for iPSC Reprogramming mRNA-LNP Kit
Press Release Mar 4, 2025
uBriGene Biosciences Submits Drug Master File for iPSC Reprogramming mRNA-LNP Kit

Faster Clinical Translation and Commercialization of Therapies Derived From iPSC Technology
uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy
Press Release Aug 19, 2024
uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy

-Super Speed of Only Nine Months